SWISSE Wellness has announced the enrolment of the first participant in the "Memory and Attention Supplement Trial" (MAST Trial).
The MAST trial will be conducted as part of a PhD program at the Centre for Human Psychopharmacology, Swinburne University, and will investigate the effects of chronic supplementation with Swisse Ultiboost Memory and Focus on memory and cognition over 12 weeks as well as how the product affects mood, general wellbeing and response to stress in relevant individuals.
If you have patients who may be suitable, contact Lauren Young on 03 9214 3793 or email laurenyoung@swinburne.edu.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jun 18
